Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-014981
Filing Date
2013-05-01
Accepted
2013-05-01 15:45:21
Documents
2
Period of Report
2013-04-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 10030
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 4194
  Complete submission text file 0001127602-13-014981.txt   15764
Mailing Address 133 BOSTON POST ROAD WESTON MA 02493
Business Address 133 BOSTON POST ROAD WESTON MA 02493 7814642000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 13802962